Skip to content

CT perfusion of the pancreas: Evaluation of predictive factors in acute pancreatitis related to endoscopic retrograde cholangiopancreatography (post-ERCP pancreatitis)

CT perfusion of the pancreas: Evaluation of predictive factors in acute pancreatitis related to endoscopic retrograde cholangiopancreatography (post-ERCP pancreatitis) - CT perfusion of the pancreas: Evaluation of predictive factors in acute pancreatitis related to post-ERCP pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020142
Enrollment
50
Registered
2015-12-14
Start date
2015-12-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile duct of pancreatic disease

Interventions

None listed

Sponsors

Hokkaido University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Scheduled ERCP for bile duct or pancreatic disease exam. 2) 20 years old of more. 3) Included in high risk group of post-ERCP pancreatitis (PEP) (meeting the following A or B) (A) Meeting one or more of the following factors i) Sphincter of Oddi dysfunction ii) History of PEP iii) Pancreatic sphincterotomy iv) Pancreatic sphincter precutting (upward incision precut) v) Difficult catheter insertion (10 min or more for cannulation, of 10 times or more of bile duct approach) vi) Vater sphincterotomy (B) Meeting two or more of the following factors. i) 50 years old or less ii) Womem iii) History of pancreatitis iv) Pancreatography or insertion of guide wire into the pancreatic duct v) Papillary balloon dilatation 4) Written informed consent is obtained.

Exclusion criteria

Exclusion criteria: 1) Absolute contraindication to iodinated contrast material 2) eGFR < 30mL/min/1.73m2 3) New York heart association classification: class III or IV. 4) Severe lung disfunction 5) Impossible to perform ERCP because of digestive tract stenosis or trismus 6) Eastern Cooperative Oncology Group performance status 4 7) Pregnant or lactating women 8) Excluded by study directors because of other considerable factor(s)

Design outcomes

Primary

MeasureTime frame
Blood volume of the pancreas after ERCP

Countries

Japan

Contacts

Public ContactKuwatani Masaki

Hokkaido University Hospital Department of Gastroenterology and Hepatology

mkuwatan@med.hokudai.ac.jp0117161161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026